MAPT and Alzheimer disease: The clinicopathologic description of Alzheimer’s disease (AD) underwent recent revisions to better characterize, on parallel continuums, the cognitive and neuropathologic features associated with beta-amyloid (Aβ) deposition, tau hyperphosphorylation, and neurodegeneration [1–5].